• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Medicare Patients Wait Average of 34 Days to See Neurologist After Referral

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 9, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 8, 2025 -- After being referred by their physician, Medicare patients wait an average of 34 days to see a neurologist, according to study published online Jan. 8 in Neurology.

Chun Chieh Lin, Ph.D., from The Ohio State University in Columbus, and colleagues conducted a cross-sectional study using a 2018 to 2019 Medicare sample of patients with a new visit to a neurologist. The primary outcome was wait time between the last visit with a referring physician and the first visit with a neurologist. A total of 163,313 Medicare beneficiaries who had a new patient visit with a neurologist in 2018 to 2019 after being referred by their physician were identified.

The researchers found that the median wait time to the index neurologist visit was 34 days; 18 percent of patients waited more than 90 days. Compared with patients with back pain, those with multiple sclerosis (MS), epilepsy, and Parkinson disease (PD) had to wait an average of 29.4, 10.4, and 9.3 days longer, respectively. No significant differences were seen in wait times across race/ethnicity and sex. No significant differences were seen in wait times across regions with varying levels of neurologist availability. The wait time was extended by an average of 11 days when patients visited a neurologist located outside of their residential or referring physician's hospital referral region.

"Patients with MS, epilepsy, and PD had to wait longer to see neurologists despite requiring complicated care best provided by neurologists," the authors write. "We need innovative approaches to improve timely access to neurologists."

Several authors disclosed ties to the medical device industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.